US Patent Issued on Feb. 24 for "Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation" (Montana Inventor)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,373, issued on Feb. 24.

"Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation" was invented by Alan Wanderer (Bozeman, Mont.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The method is for treating an individual having atrial fibrillation (AF) with administration of oral magnesium supplementation for converting atrial fibrillation to sinus rhythm. The method includes monitoring cardiac rhythms frequently (e.g. daily), importance of remaining hydrated, adding potassium if needed, and administering a dose of oral magnesium supplements for at least four to six week...